- Home
- ALDX vs NFE Comparison
ALDX vs NFE Comparison
Compare ALDX & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALDX | NFE |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.7M | 324.4M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALDX | NFE |
|---|---|---|
| Price | $1.57 | $0.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.50 | ★ $7.70 |
| AVG Volume (30 Days) | 6.0M | ★ 19.8M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.43 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,364,860,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $89.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $0.56 |
| 52 Week High | $6.18 | $6.37 |
Technical Indicators
Market Signals| Indicator | ALDX | NFE |
|---|---|---|
| Relative Strength Index (RSI) | 28.62 | 35.29 |
| Support Level | $1.07 | $0.56 |
| Resistance Level | $5.75 | $1.42 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 21.88 | 29.19 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About NFE New Fortress Energy Inc.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.